Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

According to the chief US drug regulator, Andrew von Eschenbach, the US government should not interfere

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Goldstein A.Chief U.S. drug regulator backs off-label prescribing. Internet Document: [3 pages], 6 Mar 2007. Available from: URL: http://www.bloomberg.com

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    According to the chief US drug regulator, Andrew von Eschenbach, the US government should not interfere. Pharmacoecon. Outcomes News 525, 2 (2007). https://doi.org/10.2165/00151234-200705250-00002

    Download citation

    Keywords

    • Public Health
    • Health Outcome
    • Marketing
    • Health Economic
    • Drug Company